Molsidomine potentiates the protective activity of GYKI 52466, a non-NMDA antagonist, MK-801, a non-competitive NMDA antagonist, and riluzole against electroconvulsions in mice

European Neuropsychopharmacology

Volumn 12, Issue 4, 2002, Pages 321-326

  Tutka, Piotr ^a   Olszewski, Krzysztof ^a   Woźniak, Malgorzata ^a   Kleinrok, Zdzislaw ^a   Czuczwar, Stanislaw J ^a,b   Wielosz, Marian ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Epilepsy; Excitatory amino acid antagonists; Molsidomine; NG Nitro L arginine; Nitric oxide; Seizure

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; AMINO ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; ARGININE; DIZOCILPINE; MOLSIDOMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; RILUZOLE; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; DIZOCILPINE MALEATE; ENZYME INHIBITOR; GLUTAMATE RECEPTOR; NITRIC OXIDE SYNTHASE;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG POTENTIATION; MALE; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; PROTECTION; SEIZURE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ELECTRIC SHOCK; MOTOR ACTIVITY; PHYSIOLOGY;

ANIMAL; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; DIZOCILPINE MALEATE; DRUG SYNERGISM; ELECTROSHOCK; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; MICE; MOLSIDOMINE; MOTOR ACTIVITY; NITRIC-OXIDE SYNTHASE; NITROARGININE; RECEPTORS, GLUTAMATE; RILUZOLE; SUPPORT, NON-U.S. GOV'T; ANIMALS; ANTI-ANXIETY AGENTS; BENZODIAZEPINES; NITRIC OXIDE SYNTHASE;

EID: 0036019875     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(02)00046-9     Document Type: Article

References (35)

1. Further studies on anti- and proconvulsant effects of inhibitors of nitric oxide synthase in rodents
2. Nitric oxide and nitrovasodilatators: similarities, differences and potential interactions
3. Anticonvulsive effect of AMPA receptor antagonist GYKI 52466 on 4-aminopyridine-induced cortical ictal activity in rat
4. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy
5. Une nouvelle methode simple pour explorer l'action tranquilisante. Le test de la cheminee
6. Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs
7. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice
8. G-Nitro-L-arginine impairs the anticonvulsive action of ethosuximide against pentylenetetrazol
9. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats
10. Coupling of cerebral blood flow to neuronal activity: role of adenosine and nitric oxide
11. The role of excitotoxicity in neurodegenerative disease: implications for therapy
12. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonists of AMPA/kainate receptor responses
13. G-nitroarginine in brain in vitro and in vivo
14. G-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride rotations in rats with nigral 6-hydroxydopamine lesions
15. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices
16. Permissive and obligatory roles of NO in cerebrovascular responses to hypercapnia and acetylocholine
17. Effect of riluzole on the neurological and neuropathological changes in an animal model of cardiac arrest-induced movement disorder
18. Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice
19. Sensitization to the behavioral effect of kainic acid in the mouse is mediated by nitric oxide
20. Excitatory amino acids as a final common pathway for neurologic disorders
21. A simplified method of evaluating dose-effect experiments
22. Excitatory amino acids receptors and their role in epilepsy and cerebral ischemia
23. Nitric oxide of neuronal origin is involved in cerebral blood flow increase during seizures induced by kainate
24. Inhibition of NO synthase increases the severity of kainic acid-induced seizures in rodents
25. Role of nitric oxide in pentylenetetrazol-induced seizures: age-dependent effects in the immature rat
26. The role of nitric oxide in the kainate-induced seizures in mice
27. Riluzole therapy in Huntington's disease (HD)
28. Clinical pharmacokinetics of molsidomine
29. Dose-dependent anticonvulsant and proconvulsant effects of nitric oxide synthase inhibitors on seizure threshold in a cortical stimulation model in rats
30. Nitric oxide as a neuronal messenger
31. Kainic acid seizures in the rat
32. Comparative assays of antiepileptic drugs in mice and rats
33. G-Nitro-L-arginine differentially affects glutamate- or kainate-induced seizures
34. Molsidomine enhances the protective activity of valproate against pentylenetetrazole-induced seizures in mice
35. Benzodiazepines impair and betacarbolines enhance performance in learning and memory task